Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.03 (-7.82%)
Close on Nov 17, 2026Market cap $1.29MP/E –Yield –
Scinai Immunotherapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$6.12M. The highest annual figure on record is -$6.12M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$6.12M | – |
| FY2024 | Dec 31, 2024 | -$6.99M | – |
| FY2023 | Dec 31, 2023 | -$9.19M | – |
| FY2022 | Dec 31, 2022 | -$10.50M | – |
| FY2021 | Dec 31, 2021 | -$10.39M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2023 | Jun 30, 2023 | -$2.45M | – |
| Q1 FY2023 | Mar 31, 2023 | -$3.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.12M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.48M | – |
See a number that looks wrong?